Survey (nϭ12,000), a cross-sectional self-report survey which included the SF-12 Health Survey Version 2 (SF-12v2) to assess HRQoL. Differences between patients with and without asthma were identified using chi-square tests for categorical variables and t-tests for continuous variables. Multiple regression was used to assess the association of asthma with HRQoL while accounting for potential confounds, including age, gender, number of co-morbid conditions, possession of private insurance, alcohol use, exercise behavior, and cigarette smoking. RESULTS: Seventy-six percent (nϭ9108) of respondents were familiar with asthma. Physician diagnosis of asthma was reported by 4% of the sample (nϭ415), and the remaining 96% (nϭ11,585) served as the control group. Asthma patients were younger (36 vs. 41, pϽ0.001), more likely to be female (61% vs. 50%, pϽ.001), have private insurance (60% vs. 53% pϽ0.01), drink alcohol (68% vs. 60%, pϽ.01), and had more co-morbid conditions (0.73 vs. 0.32 pϽ0.001). Relative to controls, asthma patients had lower MCS (42.41 vs. 46.99, pϽ0.001), PCS (47.27 vs. 50.58, pϽ0.001) and SF-6D health utilities (0.66 vs. 0.73, pϽ0.001). Asthma was associated with significantly lower HRQoL after adjusting for age, gender, drinking, smoking, exercise, insurance, and comorbidities, with MCS lower by 2.59 points (pϽ0.001), PCS lower by 3.15 points (pϽ0.001), and SF-6D lower by 0.05 points (pϽ0.001). CONCLUSIONS: Asthma is associated with significant HRQoL burden, even after adjusting for covariates. This analysis may underestimate the burden of asthma, as undiagnosed asthma patients were likely included in the control group. 
OBJECTIVES:
The COPD Assessment Test (CAT) is a short, validated questionnaire designed to measure the impact that Chronic Obstructive Pulmonary Disease (COPD) has on the wellbeing and daily life of people living with COPD. The eight items pertain to COPD symptoms and impact on life, and are rated using a six-point scale, ranging from zero to five. From its original paper validation, the CAT has migrated through to many electronic platforms such as the web, tablet devices, and hand-held devices. Usability testing studies have been conducted to test the migration of the CAT to these platforms. The results have proved that the migration does not alter the way in which the items are interpreted and how the questions are completed by people with COPD. More recently, the CAT has been developed for use as a smart phone app to increase accessibility for people with COPD. METHODS: A qualitative study was conducted to test the usability of the app with ten people diagnosed with COPD. Participants completed the CAT using a smart phone, and were then asked questions that probed on the usability of the questionnaire as a smart phone app. RESULTS: Due to the CAT being short and concise, the smart phone app works very well for hosting such a questionnaire. Navigating around the screen and selecting responses to the questions were completed with no major concerns for half of the patients. Others commented that the app version could benefit from the functionality of manually increasing the screen size, as this was not implemented before the usability testing was conducted, and is a common feature of smart phones. CONCLUSIONS: Although some further work is still required before the app is finalised, this study showed that the CAT has great potential for becoming accessible in many different electronic platforms. 
PRS36 BURDEN OF SMOKING ON QUALITY OF LIFE AND PRODUCTIVITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Galaznik
OBJECTIVES:
This study aimed to explore the impact of smoking on quality of life and productivity in Chronic Obstructive Pulmonary Disease (COPD). METHODS: Data from the National Health and Wellness Survey (NHWS) were used for this study. Respondents aged 40ϩ reporting diagnosis with COPD, chronic bronchitis, or emphysema in the United States in 2009 and 2010 were included, using 2010 data for individuals completing the survey in both years. The smoking group included subjects diagnosed with COPD and who reported currently smoking (nϭ1685). The former smoker group consisted of those diagnosed with COPD who reported not smoking in the last 11ϩ years (nϭ1932). Health-related quality of life (HRQoL) was assessed with the physical (PCS) and mental component summary (MCS) scores from the SF-12v2, and the SF-6D. The Work Productivity and Activity Impairment scale (WPAI) assessed productivity, including absenteeism, presenteeism, and overall work and non-work activity impairment. Multivariate generalized linear models predicted HRQoL variables using maximum likelihood estimation and an identity function. This approach was also used to predict productivity impairment, with a negative binomial distribution and a log-link function. Covariates included age, sex, race, insurance status, marital status, income, BMI, alcohol use, exercise, and asthma diagnosis. RESULTS: The multivariable results showed the following HRQoL differences between current smokers and former smokers with COPD: MCS (44.8 vs. 46.7, pϽ0.001) , PCS (35.1 vs. 35.8, pϭ0 .079), pϭ0.001) . Model results for productivity data estimated the following differences: absenteeism (3% vs. 1%, pϭ0.355) presenteeism (23% vs. 18%, pϭ0.010), overall work impairment (25% vs. 21%, pϭ0.043) and activity impairment (52% vs. 49%, pϭ0.004). CONCLUSIONS: Compared with former smokers quitting 10ϩ years prior, COPD sufferers currently smoking have poorer MCS scores, equivalent PCS and health utility scores. They also show similar absenteeism, greater presenteeism and mildly impaired overall work and activity impairment.
PRS37 EVIDENCES FOR THE DESIGN AND IMPLEMENTATION OF SMOKING CESSATION INTERVENTIONS IN MEXICO: AN ANALYSIS OF THE WILLINGNESS TO PAY FOR AN EFFECTIVE METHOD TO QUIT SMOKING
Serván Mori E, Heredia Pi IB, Reynales Shigematsu LM, Bautista Arredondo S National Institute of Public Health, Cuernavaca, Mexico OBJECTIVES: To establish the profile of the demand for interventions to quit smoking among smokers in Mexico, estimate the maximum willingness to pay (WTP) for an effective smoking cessation treatment and to identify smokers' background, environmental, demographic, and socioeconomic factors associated with this valuation. METHODS: From the Global Adult Tobacco Survey in Mexico 2009, there was selected the sample of analysis constituted by 1626 current smokers. A crosssectional study was performed. A statistical association and descriptive analysis were conducted to describe smokers and their WTP using tobacco-related background information, environmental, socioeconomic and demographic variables. RESULTS: 82.2 % of the current smokers who did not want to quit were men, whereas between those who wanted to quit, 74.9 % were men. In the latter group, 49.8 % of smokers had been consuming tobacco with a daily frequency, for more than 16 years, 57 % had made cessation attempts in the past, and around 10% knew about the existence of centers to help quit smoking. The WTP for an effective cessation method was on average $2708 Mexican pesos. An increase was identified in the WTP as the educational level is increased using as reference to the smokers without formal education. The individuals of the quintiles of socioeconomic status (SES) 4 and 5 have a major WTP that the individuals of the quintile 1.
CONCLUSIONS:
The evidence showed in the present study, will inform and support policymakers in the design and implementation of smoking cessation interventions. The study documents the need that these interventions incorporate components in correspondence with the smokers' profiles identified to improve the effectiveness of the interventions to quit smoking, among Mexican smokers. OBJECTIVES: Asthma prevalence, morbidity and mortality have continued to increase in the United States over the last decades. Disease management programs for asthma have become a priority for managed care organizations (MCOs) in order to optimize the process of care, manage utilization, and improve outcomes. The objective of this study was to investigate how MCOs currently approach asthma treatment and management and to identify their biggest challenges and opportunities in improving asthma outcomes, and to determine if publication of revised asthma guidelines by the National Heart, Lung and Blood Institute (NHLBI) in 2007 changed MCOs' approach to asthma management. METHODS: A web and paperbased survey tool was updated from a previous survey whose results were published in 2005, and administered to a national sample of 383 MCO medical directors Descriptive statistics were calculated for all variables. RESULTS: All 61 (15.9%) responding medical directors collectively serve all regions of the United States, with almost half serving Medicare and/or Medicaid patients. All directors surveyed reported that their organizations monitor asthma patients. Plans use a variety of asthma management activities, including self-management education (80%), educational materials by mail (70%), general member education (65%) and behavior modification programs (60%). Most commonly cited factors impeding the provision of effective asthma care were noncompliance with asthma treatment, the inappropriate use of medications, and the need for multiple medications. Descriptive comparisons show that results are very similar to those from the 2005 survey. CONCLUSIONS: Survey results show that health plans rely on an array of strategies to manage asthma patients. Education appears to be an essential part of most plans' approaches to disease and cost management. Comparing our results to those reported in the 2005 study, the 2007 NHLBI guidelines appear to not have greatly impacted the approach MCO's take towards asthma management. OBJECTIVES: Palavizumab (Synagis) is used in the prevention of seasonal respiratory syncytial virus (RSV) infections. The purpose of this study was to assess the impact of palavizumab use on pneumonia, bronchiolitis and all-cause costs among children. METHODS: Mississippi Medicaid data for RSV seasons October 1 -March 31 of 2009-2010 and 2010-2011 were used. For each season, pre-term children age 2 years or less at the end of the season were classified as receiving palavizumab or not. Users and non-users were matched (1:1) on age, gender, race and presence of chronic lung disease with non-users assigned the index date for the corresponding palavizumab user. Outcomes included diagnoses of pneumonia or bronchiolitis within 30 days after the index date and all-cause costs. Costs were compared using paired t-tests. Conditional logistic regression was used to assess the impact of palavizumab on prevention of pneumonia and bronchiolitis when controlling for pre-term stage. RESULTS: In the 2009-2010 season, 337 palavizumab users and 337 non-users were identified. palavizumab users had lower likelihood of diagnoses of pneumonia (OR: 0.480; 95% CI: 0.213-1.081; pϭ0.08) and bronchiolitis (OR: 0.596; 95% A58 CI: 0.333-1.068; pϭ0.07) which approached significance. Also, palavizumab users incurred significantly lower all-cause costs compared to non-users ($6,206 vs. $7,238; pϽ0.0001 The study successfully identified patients that could be attributed to PMN using a population based claims dataset. The rate of PMN identified in this analysis is alarmingly higher than any previous study. This could be explained due to two factors: 1) The unique methodology applied in this study; 2) The study population being drawn from Medicaid beneficiaries who are primarily belonging to low income groups. Future research is warranted to address the issue of PMN. 
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PRS38 A SURVEY OF ASTHMA MANAGEMENT PROGRAMS IN MANAGED CARE ORGANIZATIONS
PRS39 PALAVIZUMAB (SYNAGIS) USE AND OUTCOMES AMONG MEDICAID BENEFICIARIES
PRS41 ETHNIC DISPARITIES IN THE INHALED CORTICOSTEROID PRESCRIPTION PATTERNS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
OBJECTIVES:
Inhaled corticosteroids (ICS) are widely used in the management of chronic obstructive pulmonary disease (COPD). Prior research suggests that COPD patients' access to ICS may vary by ethnicity. The objectives of the study were to determine if there is a difference in the proportion of Hispanic and non-Hispanic White patients taking ICS for COPD and to determine the independent predictors of taking an ICS prescription in COPD patients. METHODS: The US Medical Expenditure Panel Survey (MEPS) 2007 dataset was utilized to compare ICS prescription patterns among patients with COPD. The sample size was restricted to Hispanic and non-Hispanic White patients with ICD-9CM codes for COPD between January 1 and December 31, 2007. Proportion of patients receiving ICS prescriptions within the defined timeframe was compared by ethnicity in chi-square analysis. Multivariate logistic regression was used to determine significant predictors of receiving an ICS prescription. RESULTS: Among 1057 COPD patients included in the analysis, 16% were Hispanics, 58.5% females, and the mean age of the study population was 45.8Ϯ24.5. ICS were prescribed for 5.2% of Hispanic and 17.2% of non-Hispanic White patients (pϭ0.02). Non-Hispanic White patients with COPD had 9.37 (95% CI: 1.39; 73.28) higher odds of receiving ICS prescription than Hispanic patients independent of age, marital status, education, smoking status, and health insurance. Among other risk factors, only smoking was predictive of receiving a prescription for ICS (ORϭ1.80; 95% CI: 1.03; 3.11), independent of other factors. CONCLUSIONS: Hispanic COPD patients had substantially lower odds of receiving an ICS prescription. This disparity in ICS prescription patterns may translate into suboptimal COPD management, a higher rate of exacerbations, and higher healthcare costs in this growing minority population. The differences and potential disparities in ICS use between Hispanic and non-Hispanic White COPD patients warrant further investigation. (13.4 vs. 8.8, 6.1, 3 .7) at baseline than patients in lower quartiles. During the study period, Q4 patients had significantly higher rates of inpatient visits (26.7% vs. 3.4%, 1.2%, 0.6%), emergency department visits, outpatient/other days, and prescription drug use, as well as higher healthcare costs ($19,519 vs. $4,186, $1,798, $544) , and they accounted for 75% of health care costs among AR patients. Additionally, Q4 patients had the highest AR-related costs ($662 vs. $521, $345, $155) and accounted for 40% of AR-related costs among AR patients. CONCLUSIONS: Health care costs for patients with AR were highly variable, with patients in the top quartile responsible for the majority of costs. High cost AR patients were older, had higher proportions of co-morbid conditions and higher health care resource utilization than lower cost AR patients.
PRS42 DISPARITIES IN HEALTH CARE RESOURCES USE AMONG ASTHMA PATIENTS IN BRAZIL
PRS44 EDUCATION PLAYS A VITAL ROLE IN THE ATTITUDE TOWARD THE USAGE OF PROTECTIVE METHODS AND RESULTING LESSER MORBIDITIES AMONG AGATE WORKERS
Aggarwal BD National Institute of Occupational Health (NIOH), Ahmedabad, Gujarat, India
OBJECTIVES:
To assess the awareness among Agate worker about silicosis, preventative methods, and usage of preventative methods and factors affecting the their usage. METHODS: It is a cross-sectional study among agate workers in Khambat region of Gujarat State in India. The Khambat region is known for the household agate industry, and many of workers are poorly educated and are at risk of deadly Silicosis disease due to exposure of silica dust generated by agate grinding. This study was conducted to assess the awareness level about silicosis, awareness about the protective methods, worker attitude toward health, and prevalence of actual use of protective methods to avoid silica exposure. The study was based on questionnaire based structured interviews of 82 agate workers. RESULTS: Analysis of the results suggests that majority of the workers (55%) were aware about the silicosis, harmful effect of silica-dust exposure (72%), protective methods to avoid silica-dust exposure (80%), but only minority of the workers (22%) are actually using the protective methods. Further investigation reveals the more educated workers are more likely to use the easily available protective methods than the less educated or illiterate workers, though the awareness about of the silicosis and protec-A59
